| Literature DB >> 10563058 |
.
Abstract
The prevalence of hay fever (seasonal allergic rhinitis) in the UK has been increasing; for instance, it doubled from 10 to 20 per 1000 people between the 1970s and 1980s. For a few patients with severe hay fever symptoms, it sometimes helps to give a systemic corticosteroid; one possible option is the injection of a long-acting corticosteroid, such as triamcinolone. We have previously concluded that systemic corticosteroids have only a limited role, that is, when complete control of severe symptoms is judged essential (e.g. for a wedding or exam). Here we reconsider the case for depot triamcinolone injections in the management of hay fever.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10563058 DOI: 10.1136/dtb.1999.37317
Source DB: PubMed Journal: Drug Ther Bull ISSN: 0012-6543